Emerging roles of the FBW7 tumour suppressor in stem cell differentiation

Area of Science:

• Molecular Biology
• Oncology
• Stem Cell Biology

Background:

• FBW7 (F-box and WD repeat domain-containing protein 7) is a ubiquitin E3 ligase substrate adaptor.
• It targets oncoproteins like Notch, c-Myc, cyclin E, and c-Jun for proteolysis, regulating cell cycle, growth, metabolism, differentiation, and apoptosis.
• Loss of FBW7 is linked to human cancers, and its tumor suppressor role is confirmed by tumorigenesis in FBW7-ablated mice.

Purpose of the Study:

• To investigate the role of FBW7 in stem cell differentiation.
• To explore how FBW7 loss contributes to de-differentiation or stemness acquisition in carcinomas.
• To assess the therapeutic potential of targeting FBW7 in human diseases.

Main Methods:

• Review of emerging evidence on FBW7 function in various stem cell types.
• Focus on FBW7's role in stem cell differentiation processes.
• Analysis of FBW7's relevance to human disease and therapeutic strategies.

Main Results:

• FBW7 is emerging as a key regulator of stem cell self-renewal, differentiation, survival, and multipotency.
• Evidence suggests FBW7 controls differentiation in hematopoietic, nervous, liver, and intestinal stem cells.
• Understanding FBW7's role in differentiation is critical for cancer research.

Conclusions:

• FBW7 plays a vital role in maintaining normal stem cell differentiation.
• Dysregulation of FBW7 may contribute to cancer development through stemness acquisition.
• Targeting FBW7 pathways could offer novel therapeutic avenues for cancer treatment.